A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04509947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Ad26.COV2.S
BIOLOGICAL: Placebo

Sponsor

Janssen Pharmaceutical K.K.